Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ovarian cancer trial record is now available, including its eligibility criteria, treatment arms, outcome measures, study locations, and posted results and study documents.
    Difference
    100%
    Check dated 2026-11-11T23:41:40.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.2 to v3.8.0, while the study record still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-28T23:04:41.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide terminology transition, stating that “Super Intelligence” is being used in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T23:03:40.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T23:05:00.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T23:12:42.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study record content with a generic error screen and a Home button. This indicates access is blocked rather than an update to the study details.
    Difference
    17%
    Check dated 2026-09-23T23:04:52.000Z thumbnail image

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.